Immune suppression blocks sodium-sensitive hypertension following recovery from ischemic acute renal failure

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 294, Issue 4, 2008, Pages

  Pechman, Kimberly R ^a   Basile, David P ^b   Lund, Hayley ^a   Mattson, David L ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hypertension; Ischemia; Rats; Sodium dependent

Indexed keywords

CALVASCULIN; CREATININE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; SODIUM; SODIUM CHLORIDE;

ACUTE KIDNEY FAILURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CONVALESCENCE; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; FIBROBLAST; GLOMERULUS; HISTOLOGY; HYPERTENSION; IMMUNE DEFICIENCY; IMMUNOCOMPETENT CELL; KIDNEY INTERSTITIUM; KIDNEY ISCHEMIA; MACROPHAGE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; SALT INTAKE;

ANIMALS; BLOOD PRESSURE; CELL MOVEMENT; CREATININE; DISEASE MODELS, ANIMAL; FIBROBLASTS; HYPERTENSION; IMMUNOSUPPRESSIVE AGENTS; ISCHEMIA; KIDNEY; KIDNEY FAILURE, ACUTE; MACROPHAGES; MALE; MYCOPHENOLIC ACID; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; SODIUM CHLORIDE, DIETARY; TIME FACTORS;

EID: 41749105784     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00821.2007     Document Type: Article

References (26)

1. Alvarez V, Quiroz Y, Nava M, Pons H, Rodriguez-Iturbe B. Overload proteinuria is followed by salt-sensitive hypertension caused by renal infiltration of immune cells. Am J Physiol Renal Physiol 283: F1132-F1141, 2002.
2. Basile DP, Donohoe DL, Roethe K, Mattson DL. Chronic renal hypoxia after acute ischemic injury: effect of L-arginine on hypoxia and secondary damage. Am J Physiol Renal Physiol 284: F338-F348, 2003.
3. Basile DP, Donohoe D, Roethe K, Osborn JL. Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function. Am J Physiol Renal Physiol 281: F887-F899, 2001.
4. Basile DP, Fredrich K, Alausa M, Vio CP, Liang M, Rieder MR, Greene AS, Cowley AW Jr. Identification of persistently altered gene expression in the kidney after functional recovery from ischemic acute renal failure. Am J Physiol Renal Physiol 288: F953-F963, 2005.
5. Chatziantoniou C, Dussaule JC. Insight into the mechanism of renal fibrosis; is it possible to achieve regression? Am J Physiol Renal Physiol 289: F227-F234, 2005.
6. Forbes JM, Hewitson TD, Becker GJ, Jones CL. Ischemic acute renal failure: long-term histology of cell and matrix changes in the rat. Kidney Int 57: 2375-2385, 2000.
7. Granger DN, Vowinkel T, Petnehazy T. Modulation of inflammatory response in cardiovascular disease. Hypertension 43: 924-931, 2004.
8. Humes HD, Weinberg JM. Toxic nephropathies. In: The Kidney, edited by Brenner BM and Rector FC. Philadelphia, PA: Saunders, 1986, p. 1491-1532.
9. Jo SK, Sung SA, Cho WY, Go KJ, Kim HK. Macrophages contribute to the initiation of ischaemic acute renal failure in rats. Neph Dial Transplant 21: 1231-1239, 2006.
10. Johnson RJ, Gordon KL, Suga S, Duijvestijn AM, Griffin K, Bidani A. Renal injury and salt-sensitive hypertension after exposure to catecholamines. Hypertension 34: 151-159, 1999.
11. Kelly K, Willians W, Colvin R, Meehan S, Springer T, Ramos J, Boneventure J. Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury. J Clin Invest 97: 1056-1063, 1996.
12. Lombardi D, Gordon KL, Polinksy P, Suga S, Scwartz SM, Johnson RJ. Salt-sensitive hypertension develops after short-term exposure to angiotensin II. Hypertension 33: 1013-1019, 1999.
13. Mattson DL, James L, Berdan E, Meister C. Immune suppression attenuates hypertension and renal disease in the Dahl salt-sensitive rat. Hypertension 48: 1-8, 2006.
14. Norman RA Jr, Galloway PG, Dzielak DJ, Huang M. Mechanisms of partial renal infarct hypertension. J Hypertension 6: 397-403, 1988.
15. Quiroz Y, Pons H, Gordon KL, Rincon J, Chavez M, Parra G, Herrera-Acosta J, Gomez-Garre D, Largo R, Egido J, Johnson RJ, Rodriguez-Iturbe B. Mycophenolate mofetil prevents the salt-sensitive hypertension resulting from short-term nitric oxide synthesis inhibition. Am J Physiol Renal Physiol 281: F191-F201, 2001.
16. Rabb H, Daniels F, O'Donnell M, Haq M, Saba S, Keane W, Tang WW. Pathophysiological role of T lymphocytes in renal ischemia-reperfusion injury in mice. Am J Physiol Renal Physiol 279: F525-F531, 2000.
17. Raij L, Azar S, Keane W. Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. Kidney Int 26: 137-143, 1984.
18. Rodriguez-Iturbe B, Vaziri ND, Herrera-Acosta J, Johnson RJ. Oxidative stress, renal infiltration of immune cells, and salt-sensitive hypertension: all for one and one for all. Am J Physiol Renal Physiol 286: F606-F616, 2004.
19. Schrier RW, Wang W, Poole B, Mitra A. Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. J Clin Invest 114: 5-14, 2004.
20. Sealey JE, Laragh JH. How to do a plasma renin assay. Cardiovasc Med 2: 1079-1092, 1977.
21. Spurgeon-Pechman KR, Donohoe DL, Mattson DL, Lund H, James L, Basile DP. Recovery from acute renal failure predisposes hypertension and secondary renal disease in response to elevated sodium. Am J Physiol Renal Physiol 293: F269-F278, 2007.
22. Stepkowski SM. Molecular targets for existing and novel immunosuppressive drugs. Exp Rev Mol Med http://www.expertreviews.org/ 00001769h.htm. Accessed May 11, 2006.
23. Tillyard A, Keays R, Soni N. The diagnosis of acute renal failure in intensive car: mongrel or pedigree? Anaesthesia 60: 903-914, 2005.
24. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Ronco C. Acute renal failure in critically ill patients: a multinational, multicenter study. J Am Med Assoc 294: 813-818, 2005.
25. White FN, Grollman A. Autoimmune factors associated with infarction of the kidney. Nephron 1: 93-102, 1964.
26. Zatz R, Noronha IL, Fujihara CK. Experimental and clinical rationale for use of MMF in nontransplant progressive nephropathies. Am J Physiol Regul Integr Comp Physiol 283: R1167-R1175, 2002.